BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211115
DTEND;VALUE=DATE:20211117
DTSTAMP:20260515T223802
CREATED:20210608T113322Z
LAST-MODIFIED:20210608T113525Z
UID:30480-1636934400-1637107199@www.pharmajournalist.com
SUMMARY:Medical Devices and IVD conference 2021
DESCRIPTION:Navigating new legislations and strategies to comply with regulatory requirements \nSMi is proud to announce the launch of their Medical Devices and IVD conference to be held in London in November 2021. \nThe MDR and IVDR updates will have a profound impact on the medical device industry\, bringing certain products into regulatory scope that were previously excluded\, introducing new manufacturing requirements\, and increasing the burden for post-market surveillance. What does this mean for the future of the Medical Devices and IVD industry? \nSMi’s inaugural Medical Devices and IVD conference will provide insight into the latest updates in EU MDR and IVDR regulations and will discuss strategies for how to best comply with these new regulations. In addition\, the conference will examine MHRA Guidance on Post-Brexit IVD Regulations and consider the evolving regulatory landscape for digital health software. Join Europe’s leading Medical Device and IVD Conference which will address post-market surveillance and vigilance\, clinical evaluations and investigations\, medical device regulatory affairs in global markets\, and much more. \n \nBENEFITS OF ATTENDING: \n\nEngage with notified body and competent authority representatives addressing key MDR and IVDR requirements\nGain insights from pharma regulatory experts in compliance and companion diagnostics\nUnderstand the latest guidance on Post-Brexit IVD Regulations to overcome common challenges\, in addition to considering evolving global regulations\nExamine post-market expectations for surveillance and vigilance of your medical devices\nDelve into how COVID-19 has impacted the MDR and IVD regulations\n\nView the full agenda and speaker line-up online: www.medicaldevices-ivd.com/pjwl \nPlus\, post-conference workshop will be taking place on 17th November in London: \nImplementing the EU MDR and Article 117\, An Industry Perspective \nWorkshop Leader: Blake Green\, Senior Manager Regulatory Affairs\, Amgen \nEARLY-BIRD RATES: \n\nBOOK BY 30TH JUNE AND SAVE £200\nBOOK BY 30TH SEPTEMBER AND SAVE £100\n\nRegistrations can be made on the event website at: www.medicaldevices-ivd.com/pjwl \nCHAIR FOR 2021: \nAndreas Stange\, Vice President\, TÜV SÜD \nHEAR FROM EXPERT INDUSTRY SPEAKERS: \n\nJessica Wilkerson\, Cyber Policy Advisor\, FDA\nSusan Neadle\, Executive Director\, Combination Products\, Devices\, Diagnostics & Digital Health Regulatory Affairs\, Amgen\nClaudia Dollins\, Head\, Precision Medicine & Companion Diagnostics\, Bristol Myers Squibb\nMichael Benecky\, Senior Director\, Global Regulatory Affairs\, UCB Biosciences\nChristophe Driesmans\, Head of the Materiovigilance Entity\, Federal Agency for Medicines and Health Products (FAMHP)\nMelanie Donguy\, Head Regulatory Affairs EMEA\, Bayer Radiology\nMarc Moal\, Head of Product Delivery & Project Management\, Merck Connected Health & Devices\nJim Leamon\, Director of Biologics Device Development\, Jazz Pharmaceuticals\nLouise Place\, Director\, Devices\, GlaxoSmithkline\nStefan Strasser\, Head of Department\, Austrian Medicines and Medical Devices Agency
URL:https://www.pharmajournalist.com/event/medical-devices-and-ivd-conference-2021/
LOCATION:London\, UK | Virtual Attendance Option Available
ORGANIZER;CN="SMi Group":MAILTO:hsidhu@smi-online.co.uk
END:VEVENT
END:VCALENDAR